FIELD: medicine.
SUBSTANCE: method is based on measuring the following parameters: AGT gene 704C version allele: (704TC or 704CC genotype), AGT gene 521T version allele (521CT or 521TT genotype), AGTR1 gene 1166C version allele (1166AC or 1166CC genotype), NOS3 gene 786C version allele (786TC or 786 CC genotype). There are also specified: the age of 35 and older, a bid foetus in past medical history, a patient's BWI ≥40 kg/m2, cardiovascular pathologies in relatives. That is followed by calculating a prognostic index by the formula: P=0.861 × X1+0.636 × X2+0.271 × X3+0.793 × X4+1.487 × X5+0.822 × X6+0.869 × X7+0.801 × X8 - 2.421, wherein X1 is AGT gene C allele (polymorphism 704 T>C) in the genotype (yes -1, no - 0). X2 is AGT gene T allele (polymorphism 521 C>T) in the genotype (yes -1, no - 0). X3 is AGT gene T allele (polymorphism 1166 C>T) in the genotype (yes -1, no - 0). X4 is NOS3 gene C allele (polymorphism 786 C>T) in the genotype (yes -1, no - 0). X5 is the age of 35 and older (yes -1, no - 0). X6 is a big foetus in past medical history (yes -1, no - 0). X7 is the patient's BWI >40 kg/m (if >40 kg/m -1, if not - 0). X8 is a cardiovascular pathology in relatives (yes -1, no - 0). Const=-2.42129. If P<0, no risk of developing hypertension complications is stated. If P>0, developing hypertension complications are predicted.
EFFECT: invention has high sensitivity, specificity, and efficiency; this formula enables predicting developing hypertension complications prior to clinical manifestations.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF DEVELOPING PREECLAMPSIA WITH UNDERLYING GESTATIONAL DIABETES MELLITUS IN PATIENTS AFTER USING ASSISTED REPRODUCTIVE TECHNOLOGIES | 2023 |
|
RU2821559C1 |
METHOD FOR GENETIC DIAGNOSTICS OF SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES | 2007 |
|
RU2376372C2 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING FETAL MACROSOMIA IN PATIENTS WITH GESTATIONAL DIABETES MELLITUS AFTER USING ASSISTED REPRODUCTIVE TECHNOLOGIES | 2023 |
|
RU2819022C1 |
DIAGNOSTIC TECHNIQUE FOR GENETIC PREDISPOSITION TO ISCHEMIC STROKE DEVELOPMENT IN PATIENTS WITH ATRIAL FIBRILLATION | 2015 |
|
RU2602451C1 |
METHOD FOR PREDICTING DEVELOPMENT OF PERINATAL COMPLICATIONS IN PREGNANT WOMEN AND WOMEN IN LABOR WITH EXCESS WEIGHT OR OBESITY | 2017 |
|
RU2673085C1 |
METHOD FOR DETECTING GENETIC PREDISPOSITION TO RECURRENT PREGNANCY LOSS | 2012 |
|
RU2532367C2 |
METHOD FOR PREDICTING THE RISK OF DEVELOPMENT OF PREECLAMPSIA IN PREGNANT WOMEN WITH FETAL GROWTH RESTRICTION SYNDROME | 2021 |
|
RU2754956C1 |
METHOD FOR PREDICTING THE RISK OF FETAL GROWTH RETARDATION, TAKING INTO ACCOUNT EPISTATIC INTERACTIONS OF POLYMORPHIC MENARCHE LOCI | 2021 |
|
RU2775432C1 |
METHOD FOR PREDICTION OF DEVELOPMENT OF ABNORMAL UTERINE BLEEDING IN PUBERTY PERIOD FOR ADOLESCENT GIRLS BORN WITH DELAYED PRENATAL GROWTH | 2016 |
|
RU2632106C2 |
METHOD FOR PREDICTION OF RISK OF PREECLAMPSIA IN WOMEN WITH CHRONIC ARTERIAL HYPERTENSION | 2018 |
|
RU2699974C1 |
Authors
Dates
2014-06-10—Published
2012-10-29—Filed